Rinvoqhcp.com

Visit rinvoqhcp.com
  • 534

    Daily Visitors

  • 1 month ago

    Last scanned

  • 5 years

    Domain Age

  • No data

    Global Rank

Rinvoqhcp.com

Visit rinvoqhcp.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

RINVOQ® (upadacitinib) | Official Healthcare Professional Site

RINVOQ® (upadacitinib) is approved for treatment of certain patients with RA, PsA, AD, UC, AS, nr-axSpA, and CD. See full Prescribing, Use & Safety Info, and BOXED WARNING

Rinvoqhcp.com thumbnail
Rinvoqhcp.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for rinvoqhcp.com: 3.162.125.12, 3.162.125.15, 3.162.125.29, 3.162.125.64. Moreover, DNS used with this website include ns11.constellix.com, ns21.constellix.com, ns31.constellix.com, ns41.constellix.net, ns51.constellix.net, ns61.constellix.net. Subnet identifier ranges from 3.160.0.0 to 3.163.255.255. Classless Inter-Domain Routing (CIDR) is 3.160.0.0/14. ARIN net type is Reallocated.

  • 534

    Daily Visitors

  • 1 month ago

    Last scanned

  • 5 years

    Domain Age

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of rinvoqhcp.com is MarkMonitor Inc. and the name expires on 2025-03-12. According to open source data, you can reach the owner at internetnameregistrar@abbvie.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • All Indications

Websites similar to rinvoqhcp.com

Rinvoqhcp.com friends